Your browser doesn't support javascript.
loading
A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer.
Thangavel, Hariprasad; De Angelis, Carmine; Vasaikar, Suhas; Bhat, Raksha; Jolly, Mohit Kumar; Nagi, Chandandeep; Creighton, Chad J; Chen, Fengju; Dobrolecki, Lacey E; George, Jason T; Kumar, Tanya; Abdulkareem, Noor Mazin; Mao, Sufeng; Nardone, Agostina; Rimawi, Mothaffar; Osborne, C Kent; Lewis, Michael T; Levine, Herbert; Zhang, Bing; Schiff, Rachel; Giuliano, Mario; Trivedi, Meghana V.
Afiliação
  • Thangavel H; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX 77204, USA. hthangav@central.uh.edu.
  • De Angelis C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA. carmine.deangelis@bcm.edu.
  • Vasaikar S; Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy. carmine.deangelis@bcm.edu.
  • Bhat R; Department of Translational Molecular Pathology, MD Anderson Cancer Research Center, Houston, TX 77030, USA. svvasaikar@mdanderson.org.
  • Jolly MK; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX 77204, USA. rrbhat2@central.uh.edu.
  • Nagi C; Centre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore 560012, India. mkjolly@iisc.ac.in.
  • Creighton CJ; Center for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA. mkjolly@iisc.ac.in.
  • Chen F; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA. chandandeep.nagi@bcm.edu.
  • Dobrolecki LE; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. creighto@bcm.edu.
  • George JT; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. fengjuc@bcm.edu.
  • Kumar T; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA. dobrolec@bcm.edu.
  • Abdulkareem NM; Center for Theoretical Biological Physics, Rice University, Houston, TX 77005, USA. jason.george@rice.edu.
  • Mao S; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. jason.george@rice.edu.
  • Nardone A; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX 77204, USA. tkumar5@uh.edu.
  • Rimawi M; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX 77204, USA. nabdulka@central.uh.edu.
  • Osborne CK; Department of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX 77204, USA. nabdulka@central.uh.edu.
  • Lewis MT; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA. smao@bcm.edu.
  • Levine H; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA. nardone@bcm.edu.
  • Zhang B; Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, MA 02215, USA. nardone@bcm.edu.
  • Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA. rimawi@bcm.edu.
  • Giuliano M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. rimawi@bcm.edu.
  • Trivedi MV; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. rimawi@bcm.edu.
J Clin Med ; 8(11)2019 10 24.
Article em En | MEDLINE | ID: mdl-31652963

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article